DARATUMUMAB-DFO ZR-89
UNII BF2SMF4KKT

Substance Identification & Data

This profile provides standardized clinical and technical data for Daratumumab-dfo Zr-89, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BF2SMF4KKT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BF2SMF4KKT
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DARATUMUMAB-DFO ZR-89
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C156021
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Daratumumab-dfo Zr-89. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(89)ZR-DFO-BZ-NCS-DARATUMUMAB
89ZR-DFO-DARATUMUMAB
DARATUMUMAB-DFO ZR-89
DARATUMUMAB-THIOUREA-BENZYL-DEFEROXAMINE-(89)ZR

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus